A Phase 1a/b Dose Escalation Study of the BTK/FLT3 Inhibitor Luxeptinib in Patients with Relapsed or Refractory B-Cell Malignancies
- Resource Type
- Abstract
- Authors
- Samaniego, Felipe; Sadiq, Ahad A. ; Mahadevan, Daruka; Koontz, Michael Z.; Villasboas, Jose C.; Burke, John M.; Reid, Erin G; Cherry, Mohamad; Melear, Jason; Priego, Victor ; Cobb, Patrick; Cull, Elizabeth H.; Conkling, Paul ; Cosgrove, David ; Roeker, Lindsey E.; Nguyen Haney, Donna ; Hu, Jia ; Sinha, Ranjeet Kumar ; Rice, William G; Bejar, Rafael
- Source
- In Blood 15 November 2022 140 Supplement 1:6498-6500
- Subject
- Language
- ISSN
- 0006-4971